Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China
· Delayed Price · Currency is CNY 24.94
+0.29 (1.18%)
Apr 29, 2026, 3:00 PM CST
SHA:603983 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 9,885 | 13,293 | 12,936 | 10,133 | 13,545 | 12,806 | Upgrade
|
| Market Cap Growth | -33.13% | 2.76% | 27.66% | -25.19% | 5.77% | -38.83% | Upgrade
|
| Enterprise Value | 8,552 | 11,879 | 11,157 | 8,867 | 12,281 | 10,808 | Upgrade
|
| Last Close Price | 24.65 | 33.15 | 31.67 | 24.19 | 32.02 | 30.02 | Upgrade
|
| PE Ratio | 39.76 | 53.77 | 37.87 | 39.06 | 77.76 | 51.65 | Upgrade
|
| Forward PE | 27.17 | 27.36 | 29.69 | 30.89 | 45.45 | 34.27 | Upgrade
|
| PS Ratio | 2.86 | 3.84 | 4.36 | 4.55 | 7.82 | 7.17 | Upgrade
|
| PB Ratio | 2.91 | 3.92 | 3.75 | 2.96 | 4.16 | 4.06 | Upgrade
|
| P/TBV Ratio | 3.37 | 4.53 | 4.83 | 3.86 | 5.55 | 5.52 | Upgrade
|
| P/FCF Ratio | 144.03 | 193.70 | - | 120.67 | - | - | Upgrade
|
| P/OCF Ratio | 36.09 | 48.54 | 43.05 | 29.98 | 279.64 | - | Upgrade
|
| PEG Ratio | - | 3.37 | 3.37 | 3.37 | 3.37 | 3.81 | Upgrade
|
| EV/Sales Ratio | 2.47 | 3.43 | 3.76 | 3.98 | 7.09 | 6.05 | Upgrade
|
| EV/EBITDA Ratio | 29.35 | 40.94 | 30.67 | 46.14 | 79.69 | 46.62 | Upgrade
|
| EV/EBIT Ratio | 36.96 | 51.34 | 32.89 | 50.58 | 89.26 | 49.96 | Upgrade
|
| EV/FCF Ratio | 124.61 | 173.09 | - | 105.59 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.12 | 0.12 | 0.23 | 0.08 | 0.08 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.37 | 1.37 | 2.16 | 1.28 | 1.65 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 5.80 | 5.80 | - | 3.04 | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.41 | -0.41 | -0.49 | -0.55 | -0.48 | -0.52 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.81 | -4.81 | -4.61 | -9.72 | -10.21 | -7.07 | Upgrade
|
| Net Debt / FCF Ratio | -20.34 | -20.34 | 105.88 | -22.25 | 25.19 | 13.16 | Upgrade
|
| Asset Turnover | 0.72 | 0.72 | 0.62 | 0.52 | 0.44 | 0.47 | Upgrade
|
| Inventory Turnover | 3.94 | 3.94 | 4.05 | 4.11 | 3.84 | 4.73 | Upgrade
|
| Quick Ratio | 1.55 | 1.55 | 1.59 | 2.15 | 2.88 | 3.00 | Upgrade
|
| Current Ratio | 1.87 | 1.87 | 1.85 | 2.50 | 3.35 | 3.43 | Upgrade
|
| Return on Equity (ROE) | 7.21% | 7.21% | 9.97% | 8.32% | 5.22% | 7.83% | Upgrade
|
| Return on Assets (ROA) | 2.99% | 2.99% | 4.46% | 2.56% | 2.19% | 3.58% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.88% | 10.25% | 18.39% | 9.51% | 6.98% | 15.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.80% | 6.80% | 9.80% | 5.10% | 4.00% | 6.80% | Upgrade
|
| Earnings Yield | 2.50% | 1.86% | 2.64% | 2.56% | 1.29% | 1.94% | Upgrade
|
| FCF Yield | 0.69% | 0.52% | -0.12% | 0.83% | -0.46% | -0.97% | Upgrade
|
| Dividend Yield | 1.98% | 1.51% | 2.37% | 2.15% | 0.78% | 0.63% | Upgrade
|
| Payout Ratio | 121.70% | 121.70% | 91.66% | 40.90% | 44.08% | 57.24% | Upgrade
|
| Buyback Yield / Dilution | 0.78% | 0.78% | -0.70% | 1.47% | -1.30% | 0.12% | Upgrade
|
| Total Shareholder Return | 2.76% | 2.29% | 1.66% | 3.62% | -0.52% | 0.75% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.